Cafepharma Today

Memorial Day Weekend 2025
We wish all our US visitors a safe and enjoyable holiday weekend. We remember those who have given their lives to defend and protect our country.

CP Today will resume on Tuesday, May 27

*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Auxilium Falls Most in Year as Pfizer Deal Ends
Bloomberg
Thursday, November 8, 2012 - 10:53am
tags:
Pfizer, Auxilium, Xiapex, Dupuytren's Contracture
Ariad's on the Launchpad
Motley Fool
Thursday, November 8, 2012 - 10:51am
tags:
Ariad Pharmaceuticals, earnings
Immune Pharmaceuticals and EpiCept Corporation Agree to Merge
Yahoo
Thursday, November 8, 2012 - 10:51am
tags:
M&A, EpiCept, Immune Pharmaceuticals
Vical's Allovectin: Update On The Phase III Trial
Seeking Alpha
Thursday, November 8, 2012 - 10:50am
tags:
Vical, Allovectin, Bristol-Myers Squibb, JNJ, melanoma
India's Ranbaxy beats estimates on higher sales, forex gain
Reuters
Thursday, November 8, 2012 - 10:49am
tags:
Ranbaxy, India, earnings
NeoStem To Create Value With Billion Dollar Potential
Seeking Alpha
Wednesday, November 7, 2012 - 12:39pm
tags:
NeoStem, Neuralstem, Osiris, StemCells
Amyris Advances Most in Two Weeks After Reporting Narrower Loss
Bloomberg
Wednesday, November 7, 2012 - 12:37pm
tags:
Amyris
AHA - 2 Hits And Several Misses With Novartis' Serelaxin
Seeking Alpha
Wednesday, November 7, 2012 - 12:36pm
tags:
Novartis, serelaxin, heart failure, shortness of breath
Is Big Pharma Utilizing Too Many Resources on Potential Blockbusters?
Forbes
Wednesday, November 7, 2012 - 12:35pm
tags:
Xalkori, lung cancer, Pfizer
Illinois Medicaid, manufacturer settle suit over premature birth drug
Crain's Chicago Business, IL
Wednesday, November 7, 2012 - 11:58am
tags:
Illinois, Medicaid, premature birth, Makena, KV Pharmaceutical
FDA Rejects Petition To Ban Pfizer Alzheimer Pill
Pharmalot
Wednesday, November 7, 2012 - 11:57am
tags:
FDA, Alzheimer's disease, Public Citizen, Pfizer, Aricept
Why Investors Are Voting Against Novo Nordisk
Motley Fool
Wednesday, November 7, 2012 - 11:55am
tags:
Novo Nordisk, FDA, advisory panels, Tresiba, insulin
Merck May Not Have Shown Women Can Safely Choose Drug
Bloomberg
Wednesday, November 7, 2012 - 11:47am
tags:
Merck, Oxytrol, overactive bladder
Hot Off the Press: Pfizer Goes After Abbott
Motley Fool
Wednesday, November 7, 2012 - 11:40am
tags:
Abbott Labs, Pfizer, Xeljanz, tofacitnib, rheumatoid arthritis
Amarin Stagnates On Frustrating M&A Speculation And (More) Waiting
Seeking Alpha
Wednesday, November 7, 2012 - 11:22am
tags:
M&A, Amarin, GSK
Novartis Pregnancy Hormone Seen Lessening Heart Failures
Bloomberg
Wednesday, November 7, 2012 - 11:21am
tags:
heart failure, Novartis, RLX030
Buyout Buzz: The most frequently cited takeover targets in biotech
Fierce Biotech
Tuesday, November 6, 2012 - 4:32pm
tags:
biotech, M&A, Amarin, Achillion, ONYX Pharmaceuticals, Actelion, Elan, Forest Labs, Medivation, Biomarin, Indenix
Strong 1Q from Myriad, Guidance Up
Yahoo/Zacks.com
Tuesday, November 6, 2012 - 4:24pm
tags:
earnings, guidance, Myriad Genetics
5 Companies Dominating Diabetes
Motley Fool
Tuesday, November 6, 2012 - 4:21pm
tags:
diabetes, AstraZeneca, Bristol-Myers Squibb, Sanofi, Novo Nordisk, MannKind
Vivus Weight-Loss Drug Launch In Early Trouble
TheStreet.com
Tuesday, November 6, 2012 - 12:30pm
tags:
Vivus, Qsymia

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.